| Literature DB >> 26966684 |
Stefan Kalkhof1, Stefan Schildbach2, Conny Blumert3, Friedemann Horn3, Martin von Bergen4, Dirk Labudde2.
Abstract
The functionality of most proteins is regulated by protein-protein interactions. Hence, the comprehensive characterization of the interactome is the next milestone on the path to understand the biochemistry of the cell. A powerful method to detect protein-protein interactions is a combination of coimmunoprecipitation or affinity purification with quantitative mass spectrometry. Nevertheless, both methods tend to precipitate a high number of background proteins due to nonspecific interactions. To address this challenge the software Protein-Protein-Interaction-Optimizer (PIPINO) was developed to perform an automated data analysis, to facilitate the selection of bona fide binding partners, and to compare the dynamic of interaction networks. In this study we investigated the STAT1 interaction network and its activation dependent dynamics. Stable isotope labeling by amino acids in cell culture (SILAC) was applied to analyze the STAT1 interactome after streptavidin pull-down of biotagged STAT1 from human embryonic kidney 293T cells with and without activation. Starting from more than 2,000 captured proteins 30 potential STAT1 interaction partners were extracted. Interestingly, more than 50% of these were already reported or predicted to bind STAT1. Furthermore, 16 proteins were found to affect the binding behavior depending on STAT1 phosphorylation such as STAT3 or the importin subunits alpha 1 and alpha 6.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26966684 PMCID: PMC4761381 DOI: 10.1155/2016/2891918
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Interaction databases used to create a PPI netpwork. Databases marked with an asterix (∗) had been taken from the IMEx interface (http://www.ebi.ac.uk/intact/imex/main.xhtml) instead from direct database sources. An interaction was counted as invalid with one of the following reasons: it does not have a valid UniProt accession number or it could not be mapped to one, it has no valid gene name or it could not be mapped to one, or it has no valid taxonomy ID or it could not be mapped to one. Unfortunately, some mapping processes do not yet cover a large percentage of specific databases (cf. DIP with 97% invalid interactions or InnateDB with 100% invalid interactions).
| Name | Date | Interactions | IMEx | ||
|---|---|---|---|---|---|
| Total | Invalid | Valid | |||
| Mentha | 17.08.14 | 461,408 | 47.236 (10%) | 414.172 (90%) |
|
| IntAct | 18.07.14 | 424,706 | 128.680 (28%) | 326.026 (72%) | ✓ |
| BioGRID | 01.08.14 | 749,913 | 493.819 (66%) | 256.094 (34%) | ✓ |
| MINT | 26.03.13 | 122,356 | 17.968 (15%) | 104.388 (85%) | ✓ |
| PIPs | 12.09.08 | 34,216 | 9.466 (28%) | 24.750 (72%) |
|
| HPRD | 13.04.10 | 39,240 | 29.288 (75%) | 9.952 (25%) |
|
| UniProt | 18.08.14 | 11,919 | 2.272 (19%) | 9647 (81%) | ✓ |
| DIP | 07.01.14 | 107,619 | 104.050 (97%) | 3.569 (03%) | ✓ |
| MPIDB | 18.08.14 | 1,759 | 767 (44%) | 992 (56%) | ✓ |
| I2D | 18.08.14 | 1,117 | 263 (24%) | 854 (76%) | ✓ |
| BHF-UCL | 18.08.14 | 911 | 315 (35%) | 596 (65%) | ✓ |
| InnateDB | 17.08.14 | 680 | 93 (14%) | 587 (86%) | ✓ |
| MatrixDB | 18.08.14 | 1,244 | 864 (69%) | 380 (31%) | ✓ |
| MolCon | 18.08.14 | 495 | 129 (26%) | 366 (74%) | ✓ |
| MBInfo | 18.08.14 | 638 | 306 (48%) | 332 (52%) | ✓ |
Figure 1Utilization of PIPINO during preparation, data processing, and visualization of experimental AP-MS data.
Figure 2Volcano plots of results of the STAT1 AP-MS experiment. (a) The mean log2 ratios of STAT1-Bio with EPO treatment versus GFP-Bio are plotted versus the corresponding p values. X proteins are being depicted in red passing the thresholds of p value below 0.005 and log2-FC > 1 and were treated as putative STAT1 binding partners. (b) Analogously the volcano represents the AP-MS analysis of phosphorylated STAT1 versus GFP control. (c) Representation of the STAT1 activation experiments. Proteins which are identified as putative binding partners or which are derived as PPIs from literature are plotted depending on their binding properties to phosphorylated (enriched shown in blue) or nonphosphorylated (enriched shown in red) STAT1 proteins.
Figure 3Different network layouts in different detail levels. (a) A specialized STAT1-centric network containing experimentally and literature derived PPIs arranged by a force field. (b) The same data depicted with a radial layout. (c) The corresponding truncated network arranged by a force field. (d) A detailed zoom-in of the hierarchical layout. (e) A truncated subnetwork with a scoring threshold of 0.85. Green nodes represent interaction partners not found in the experiment (only listed in database entries), the blue nodes are confirmed interaction partners (found in the databases and the experiment), and the red nodes represent the protein of interest.
AP-MS data of all proteins being determined as putative interaction of phosphorylated and/or nonphosphorylated STAT1. Significant enrichments are highlighted in bold.
| Gene name | Binding to phosphorylated STAT1 | Binding to nonphosphorylated STAT1 | Binding depending on phosphorylation |
Known | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| STAT1 + EPO versus GFP | STAT1 versus GFP | STAT1 + EPO versus STAT1 | ||||||||
| log2 ratio | Standard deviation |
| log2 ratio | Standard deviation |
| log2 ratio | Standard deviation |
| ||
| CHCHD3 | −1.78 | 1.17 | 5.9 | 1.32 | 0.22 | 4.4 | −4.35 | 1.20 | 2.4 | No |
| ETFB | −1.48 | 0.58 | 2.3 | 2.45 | 0.12 | 4.1 | −4.33 | 1.01 | 1.8 | No |
| NDUFS3 | −2.16 | 0.84 | 2.3 | 1.29 | 0.10 | 1.0 | −3.82 | 1.02 | 2.3 | No |
| UBE2M | −0.06 | 0.13 | 2.4 | 1.93 | 0.33 | 4.9 | −3.53 | 0.54 | 7.7 | No |
| UCHL1 | −0.86 | 0.48 | 4.5 | 2.27 | 0.37 | 4.3 | −3.48 | 1.10 | 3.2 | No |
| PFKL | 0.26 | 0.45 | 2.1 | 1.82 | 0.26 | 3.5 | −2.44 | 0.26 | 3.7 | No |
| PGD | −0.18 | 0.72 | 3.3 | 1.18 | 0.13 | 1.8 | −1.20 | 0.97 | 9.1 | No |
| ERP44 | −0.49 | 0.43 | 5.3 | 1.58 | 0.47 | 3.4 | −1.10 | 0.99 | 1.1 | No |
| CANX | −0.40 | 0.45 | 8.6 | 1.70 | 0.53 | 3.9 | −1.09 | 1.26 | 1.8 | No |
| PYGL | −0.02 | 0.29 | 4.5 | 1.26 | 0.33 | 2.4 | −0.97 | 0.79 | 9.0 | No |
| UQCRC1 | 0.29 | 0.30 | 4.6 | 1.30 | 0.45 | 1.5 | −0.68 | 0.70 | 9.4 | No |
| GLO1 | 0.96 | 0.83 | 5.1 | 2.29 | 0.20 | 9.5 | −0.66 | 1.00 | 2.8 | No |
| HSD17B4 | −0.06 | 0.39 | 4.1 | 1.54 | 0.36 | 1.7 | −0.44 | 0.72 | 4.0 | No |
| FARSB | −0.24 | 0.49 | 2.0 | 1.11 | 0.25 | 1.5 | −0.37 | 0.83 | 4.4 | No |
| STAT2 | 3.35 | 0.38 | 2.0 | 3.23 | 0.55 | 6.5 | −0.24 | 0.65 | 5.2 | Yes |
| ACTG1 | 1.08 | 0.61 | 3.6 | 0.34 | 0.24 | 1.6 | 0.42 | 0.86 | 3.4 | No |
| TBCA | 1.25 | 0.76 | 1.0 | 1.36 | 0.54 | 2.4 | 0.72 | 1.08 | 2.1 | No |
| SPTAN1 | 1.22 | 0.25 | 1.1 | 0.37 | 0.36 | 6.6 | 0.75 | 0.48 | 5.1 | Yes |
| STAT1 | 5.61 | 0.53 | 8.1 | 4.47 | 0.75 | 1.4 | 0.97 | 1.02 | 6.9 | Yes |
| LDHB | 1.06 | 0.30 | 1.7 | −0.16 | 0.47 | 2.2 | 1.09 | 0.89 | 3.0 | Yes |
| STMN1 | 1.45 | 0.19 | 3.0 | −0.39 | 0.70 | 1.7 | 1.26 | 1.26 | 1.4 | No |
| PABPC3 | 1.28 | 0.18 | 3.3 | −0.59 | 0.43 | 7.2 | 1.43 | 0.29 | 1.3 | No |
| CAPRIN1 | 1.13 | 0.28 | 4.1 | −0.32 | 0.24 | 2.2 | 1.55 | 0.58 | 4.0 | No |
| PTBP2 | 1.16 | 0.06 | 3.8 | −0.63 | 0.02 | 1.3 | 1.71 | 0.07 | 6.1 | No |
| DES | 2.11 | 0.61 | 3.1 | −0.30 | 0.48 | 1.5 | 2.25 | 0.73 | 8.6 | No |
| PLEC | 1.74 | 0.24 | 3.1 | −1.23 | 0.89 | 7.0 | 2.86 | 0.71 | 2.0 | Yes |
| INA | 3.28 | 0.52 | 4.1 | −0.32 | 0.49 | 1.9 | 2.97 | 0.17 | 1.1 | No |
| KPNA6 | 1.99 | 0.26 | 2.9 | −1.50 | 0.13 | 1.3 | 3.18 | 0.51 | 8.3 | Yes |
| KPNA1 | 3.90 | 0.31 | 1.0 | −1.06 | 0.29 | 1.2 | 3.67 | 0.58 | 1.1 | Yes |
| STAT3 | 3.45 | 0.05 | 3.9 | −2.67 | 0.31 | 2.2 | 5.28 | 0.40 | 1.9 | Yes |